2026-10-25
EQT clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 28,436 +0.18%
S&P 7,613 +0.44%
GOLD $3,975 +1.95%
BTC $77,056 −1.52%
VIX 19.75 +1.70%
latest tape · as of 18:19 UTC
The Screen · Energy · Oil & Gas E&P
EQT Corporation
EQT · a US exchange · USD · Market cap $34.6B · 1,523 employees
EQT Corporation engages in the exploration, production, gathering, and transmission of hydrocarbons and natural gas.
Not yet scored55.38 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 18:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price55.38 USD at the 30 Oct 2026 close
- Our ratingQuality, fully valued, current read accumulation
- Ethical screenNot yet scored
- OptionsOpen interest leans slightly to calls (put/call 0.86)
- Last reviewed30 Oct 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $43.27 to $49.76, base estimate $43.27 (screen dated 2026-10-30).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.86, read 2026-11-01
- Ethical screen not yet scored
Price55.38 USD
Fair value43.27
Ethical score88.6/100
RatingQUALITY, FULLY VALUED
Our investment reviews on this name
2026-10-14Read Accumulation52.83+4.8% to today ✓Markdown gives way to Accumulation after a 6% rise in 12 days
2026-10-02Read Markdown49.87+11.0% to today Accumulation gives way to Markdown after a 7% slide in 5 weeks
2026-08-28Read Accumulation53.72+3.1% to today ✓Markdown gives way to Accumulation
2026-07-02Read Markdown53.75+3.0% to today First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
EQT Corporation holds its Accumulation at $55.38. Elevated stress, defensive posture warranted, held for 71 days.
| Phase | Accumulation |
| Quantitative state | Elevated stress, defensive posture warranted, held for 71 days |
| Price at the screen | $55.38 |
| Valuation | 13.12 trailing · 15.78 forward price to earnings |
| Values screen | Not scored · score 88.6 |
| Beta | 0.65 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 18.80% | Below 33% | Interest-bearing debt is just 18.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 8.69% | Below 33% | Cash held in interest-bearing accounts and securities is 8.7% of assets, under the one-third limit. | Pass |
| Receivables | 3.75% | Below 49% | Money owed to the company is 3.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
EQT clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
EQT clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 19%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads QUALITY, FULLY VALUED: it trades above our $43.27 fair value estimate, moderate competitive moat.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. The price runs 21.9% above the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $43.27, with a range of $43.27 to $49.76, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGas producer showing momentum near fair value
Picture an Appalachian wellhead humming away while prices swing like a pendulum. EQT sits right in that flow, selling natural gas and liquids into a market that still needs the molecule. The business is posting 50% revenue growth, 35% profit margins and a moderate moat, all at a forward multiple of 11.9 times. That combination explains the strong opportunity tag and the narrow 4% margin above our $51.66 fair value.
Numbers like these stand out because the company clears our ethical screen and shows real cash generation rather than just hoped-for reserves. ROE at 13% is decent for the sector, and the analyst crowd leans buy with a median target well above the current $49.56 price. The setup looks attractive on paper.
Yet this remains a classic cyclical business where low multiples often signal peak earnings rather than a bargain. Energy prices can drop fast, and any volume or cost miss would compress those margins quickly. The modest safety cushion leaves little room for disappointment. Analysis, not advice.
| Forward P/E | 15.8xreasonably valued |
| Trailing P/E | 13.1xreasonably valued |
| EPS, trailing | 4.22 |
| EPS, forward | 3.51 |
| Revenue growth | -8.1%revenue is shrinking |
| Profit margin | 29.0%healthy profit margins |
| Return on equity | 10.5%a modest return on shareholder capital |
| FCF yield | 7.15% |
| Dividend yield | 1.17% |
| Debt to equity | 0.19minimal debt: a conservative balance sheet |
| Current ratio | 0.71below 1: short-term bills exceed liquid assets |
| Beta | 0.65steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 47.94 - 68.24 |
| Moat | MODERATE |
| Market cap | $34.6B |
| Employees | 1,523 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeEQT trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-27
Accumulation $52.45
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Accumulation $52.45
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (26 analysts) rates it buy, with a mean price target of $67. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation $52.45
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (26 analysts) rates it buy, with a mean price target of $67. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24
Accumulation $52.45
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (26 analysts) rates it buy, with a mean price target of $67. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23
Accumulation $52.45
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (27 analysts) rates it buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22
Accumulation $52.45
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (27 analysts) rates it buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Accumulation $52.45
+0.0% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (27 analysts) rates it buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20
Accumulation $52.45
-0.7% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (27 analysts) rates it buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14
Accumulation · changed $52.83
+5.9% Entry 7
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (26 analysts) rates it strong buy, with a mean price target of $67.
2026-10-02
Markdown · changed $49.87
-7.2% Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 0%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (26 analysts) rates it strong buy, with a mean price target of $67.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Top oil & gas exploration stocks, according to Mizuho Yahoo Finance · 3d ago
- EQT (EQT) Reports Q3 Earnings: What Key Metrics Have to Say Yahoo Finance · 3d ago
- EQT (EQT) Deal Sparks Fresh Marcellus And Utica Takeover Talk Yahoo Finance · 4d ago
- EQT (EQT) Stock Fair Value Edges Lower As Analysts Weigh Range Deal And Gas Risks Yahoo Finance · 4d ago
- EQT and Range Resources Are Merging: Is It Time to Buy the New U.S. Natural Gas Titan? Yahoo Finance · 4d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
TPLTexas Pacific Land Corporation
EXEExpand Energy
DVNDevon Energy
FANGDiamondback Energy
PRPermian Resources Holdings Inc
OXYOccidental Petroleum
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-27 | BAILEY VICKY A | Director | 4,116 | $246,137 | |
| 2026-04-14 | MCCARTNEY JOHN F | Director | 4,116 | · | |
| 2026-04-14 | KARAM THOMAS F | Director | 4,116 | · | |
| 2026-04-14 | VANDERHIDER HALLIE A | Director | 4,116 | · | |
| 2026-04-14 | JACKSON KATHRYN JEAN | Director | 4,116 | · | |
| 2026-04-14 | BAILEY VICKY A | Director | 4,116 | · | |
| 2026-03-16 | FENTON SARAH | Officer | 4,876 | $314,453 | |
| 2026-03-12 | BOLEN J.E.B. | Officer | 7,634 | $491,248 | |
| 2026-03-09 | BOLEN J.E.B. | Officer | 8,630 | · | |
| 2026-03-09 | JAMES TODD M. | Officer | 19,417 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-27 | Michael McCaul | Republican | buy | 1K–15K |
| 2026-08-27 | Michael McCaul | Republican | buy | 1K–15K |
| 2026-08-27 | Michael McCaul | Republican | buy | 1K–15K |
| 2026-08-24 | Michael McCaul | Republican | buy | 1K–15K |
| 2026-08-24 | Michael McCaul | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $56.45 | -6.3% | · | $937 | -6.3% |
| 2 months | $58.52 | -9.6% | $0.17 | $907 | -9.3% |
| 3 months | $64.46 | -18.0% | $0.17 | $823 | -17.7% |
| 6 months | $55.76 | -5.2% | $0.33 | $954 | -4.6% |
| 1 year | $53.11 | -0.4% | $0.65 | $1,008 | +0.8% |
| 2 years | $40.04 | +32.1% | $1.29 | $1,353 | +35.3% |
| 3 years | $36.94 | +43.2% | $1.91 | $1,483 | +48.3% |
| 5 years | $21.50 | +145.9% | $2.76 | $2,588 | +158.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever EQT does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.